OD2 LONG-ACTING RISPERIDONE IN SCHIZOPHRENIC PATIENTS COMPARED WITH ORAL OLANZAPINE AND HALOPERIDOL DECANOATE-A COST-EFFECTIVENESS ANALYSIS
Abstract
Authors
PM Llorca JG Jasso Mosqueda H Miadi-Fargier I Durand-Zaleski C Lanon F Casadebaig A Philippe P Guillon A Mehnert A Chicoye